by Christa Myers, Process Engineer, and Marc Pelletier, PhD, Process Specialist
During a global pandemic, the pharmaceutical industry must juggle the need for speed and the need to protect patient safety. A strong regulatory strategy makes it possible to accelerate drug development without getting slowed down by compliance considerations.
Engaging our employees in our strong safety culture this Safety Month
Tetra Tech’s employee participation and engagement are vital to the success of our Health & Safety program—we strive to engage more employees each year during Safety Month. We believe a successful safety program must include engaging employees in various safety processes at all levels.
When employees are well informed about safety practices in their workplace, they are more aware of their surroundings. Research shows that 70 percent fewer safety incidents occur in highly engaged workplaces, which is a win-win for both employees and employers.
Now more than ever, we recognize that your company needs to minimize business interruption, maintain business continuity, and build resilience for the future. This is especially critical for highly regulated industries like financial services, government, as well as healthcare and life sciences. Security and compliance have never been more important, especially as employees rapidly move to working remotely.
Funding supports efforts by National Organization for Rare Disorders (NORDⓇ) and Global Genes to address needs of the rare disease community arising from COVID-19 pandemic
BOSTON, June 24, 2020 /3BL Media/ -- The Alexion Charitable Foundation, launched by Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in February 2020, has announced it has awarded a total of $1.1 million in initial grants that align with its Rare Belonging® focus. Rare Belonging seeks to advance emotional well-being and educational opportunities, and provide relief for critical needs, for those living with or affected by a rare disease.
- Special Edition of Alkermes Inspiration Grants® Program Focused on Addressing Pandemic-Related Needs of People Living with Addiction, Serious Mental Illness, or Cancer -
DUBLIN, June 24, 2020 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) today announced that 10 nonprofit organizations have been awarded grants from the company's COVID-19 Relief Fund, a special edition of the company's signature Alkermes Inspiration Grants® program, that was established to assist nonprofit organizations in their work to rapidly address pandemic-related needs for people living with addiction, serious mental illness, or cancer.
Along with the Society for Immunotherapy of Cancer we strive for a future #Immune2Cancer because to our team, cancer immunotherapy research is personal. Our scientists are researching potential, new cancer treatment options for our loved ones and yours.
This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.
Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.